Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute lymphoblastic leukemia
- PMID: 16640004
Deep sedation with methohexital or thiamylal with midazolam for invasive procedures in children with acute lymphoblastic leukemia
Abstract
Pediatric oncology/hematology patients, especially those with acute lymphoblastic leukemia (ALL), often undergo repeated painful invasive procedures. Deep sedation, mandatory for these procedures in young children, can reduce patient anxiety and get their compliance during procedures. This study assessed clinical experience of employing methohexital or thiamylal with midazolam as sedative for elective invasive procedures in children with ALL. Between November 1997 and March 2004, 20 out of 33 ALL children received deep sedation after evaluation, mainly because of relatively young age (mean age 4.60 +/- 2.03 years). A total of 176 procedures were done, with 139 being intrathecal therapy. There were 98 and 78 procedures for the methohexital and thiamylal groups, respectively. The average dosages to complete the procedures were 2.2 +/- 1.2 mg/kg for methohexital and 3.4 +/- 2.1 mg/kg for thiamylal. One out of the 176 procedures was failed due to bradycardia, hypotension and cyanosis, in the methohexital group. Otherwise, no significant adverse events were found. Increased heart rate (HR) during stable blood pressure (BP) was observed in both groups. In conclusion, under careful monitoring and performed by experienced practitioners, the application of methohexital or thiamylal combined with midazolam to achieve deep sedation for invasive procedures in young children with ALL is safe.
Similar articles
-
Brief unconscious sedation for painful pediatric oncology procedures. Intravenous methohexital with appropriate monitoring is safe and effective.Am J Pediatr Hematol Oncol. 1993 Nov;15(4):370-6. Am J Pediatr Hematol Oncol. 1993. PMID: 8214358
-
Sedation with midazolam and ketamine for invasive procedures in children with malignancies and hematological disorders: a prospective study with reference to the sympathomimetic properties of ketamine.Pediatr Hematol Oncol. 2003 Jun;20(4):291-301. Pediatr Hematol Oncol. 2003. PMID: 12746161
-
Moderate intravenous sedation with fentanyl and midazolam for invasive procedures in children with acute lymphoblastic leukemia.J Pediatr Oncol Nurs. 2009 Jul-Aug;26(4):217-22. doi: 10.1177/1043454209339733. J Pediatr Oncol Nurs. 2009. PMID: 19726793
-
[Midazolam administered orally as premedication in children in the ophthalmology department].Klin Oczna. 1997;99(6):397-400. Klin Oczna. 1997. PMID: 9685788 Clinical Trial. Polish.
-
Use of intravenous ketamine-midazolam association for pain procedures in children with cancer. A prospective study.Paediatr Anaesth. 1999;9(1):61-8. Paediatr Anaesth. 1999. PMID: 10712717
Cited by
-
Study to determine guidelines for pediatric colonoscopy.World J Gastroenterol. 2017 Aug 21;23(31):5773-5779. doi: 10.3748/wjg.v23.i31.5773. World J Gastroenterol. 2017. PMID: 28883703 Free PMC article.